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Background: ST2 is a peptide structurally comparable with the interleukin (IL) 1 receptor family and binds IL33. It has been shown to be induced 
in conditions of myocardial stretch and plays a cardioprotective role. Previous studies have demonstrated elevated serum ST2 in patients with 
pulmonary diseases, acute heart failure, acutely dyspnoeic patients, chronic heart failure and acute coronary syndromes (ACS).
Methods: Patients attending the Emergency Department with chest pain suspicious of ACS were prospectively recruited between November 2007 
and April 2010 and underwent standard measurement of core laboratory TNI, point of care BNP, CKMB and myoglobin, with additional samples later 
analysed for ST2 at 0 and 2 hours post presentation. Patients were followed to present day with primary end-point defined as composite of all cause 
mortality and heart failure.
Results: A total of 995 patients were recruited, 321 (32.3%) were diagnosed with ACS. At a median of 1.2 (0.8-1.9) years follow-up, 113 (11.4%) 
experienced a primary outcome event. The ROC curve derived AUC (95% confidence interval) for the primary outcome was 0.73 (0.67-0.78) 
compared with BNP 0.86 (0.82-0.89) and TNI 0.68 (0.63-0.74). ST2 still conveyed risk for the primary outcome even after adjustment for other 
biomarkers including BNP, hazard ratio 3.1 (2.1-4.7, p<0.001).
Conclusions: ST2 conveys risk of death and heart failure in patients presenting to the Emergency Department with chest pain. Further studies are 
required to investigate whether measurement of ST2 can influence treatment and outcome.
